Clinical Trials Directory

Trials / Unknown

UnknownNCT01374737

ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children

ED50 of Dexmedetomidine for Reduction of Emergence Agitation Incidence Undergoing Tonsillectomy or Adenoidectomy in Desflurane Anesthesia Following Sevoflurane Induction in Children

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
2 Years – 12 Years
Healthy volunteers
Not accepted

Summary

There are several recommended doses of dexmedetomidine for prevention of emergence agitation in children. In this study, the investigators examine ED50 in prevention of emergence agitation after tonsillectomy or adenoidectomy in children.

Detailed description

To investigate ED50, Dixon's up and down method will be used.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidinedexmedetomidine, 0.1ug/kg up or down

Timeline

Start date
2011-06-01
Primary completion
2011-12-01
Completion
2012-02-01
First posted
2011-06-16
Last updated
2011-06-16

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01374737. Inclusion in this directory is not an endorsement.

ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children (NCT01374737) · Clinical Trials Directory